Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 6976 - 7000 of 8282 in total
Ornidazole has been used in trials studying the prevention of Elective Colorectal Surgery.
Investigational
Matched Description: … Ornidazole has been used in trials studying the prevention of Elective Colorectal Surgery. …
MK-0873 has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … MK-0873 has been used in trials studying the treatment of Rheumatoid Arthritis. …
Niobium has been used in trials studying the treatment of Obesity and Overweight.
Investigational
Matched Description: … Niobium has been used in trials studying the treatment of Obesity and Overweight. …
CP-195,543 has been used in trials studying the treatment of Arthritis, Rheumatoid.
Investigational
Matched Description: … CP-195,543 has been used in trials studying the treatment of Arthritis, Rheumatoid. …
PF-03814735 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Description: … PF-03814735 has been used in trials studying the treatment of Solid Tumors. …
CEP-37440 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Description: … CEP-37440 has been used in trials studying the treatment of Solid Tumors. …
ME-344 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Description: … ME-344 has been used in trials studying the treatment of Solid Tumors. …
AZD0424 has been used in trials studying the treatment of Advanced Solid Tumours.
Investigational
Matched Description: … AZD0424 has been used in trials studying the treatment of Advanced Solid Tumours. …
CT-2584 has been used in trials studying the treatment of Prostate Cancer.
Investigational
Matched Description: … CT-2584 has been used in trials studying the treatment of Prostate Cancer. …
Hydroxypropyl tetrahydropyrantriol has been used in trials studying the basic science of Aging.
Investigational
Matched Description: … Hydroxypropyl tetrahydropyrantriol has been used in trials studying the basic science of Aging. …
Troxerutin has been used in trials studying the treatment of Chronic Venous Insufficiency.
Investigational
Matched Description: … Troxerutin has been used in trials studying the treatment of Chronic Venous Insufficiency. …
Agn 201904 has been used in trials studying the prevention of Peptic Ulcer.
Investigational
Matched Description: … Agn 201904 has been used in trials studying the prevention of Peptic Ulcer. …
First-in-class potent and selective inhibitor of the BRD4 signaling pathway.
Investigational
Matched Description: … First-in-class potent and selective inhibitor of the BRD4 signaling pathway.[A252967] …
ASP-7317 consists of human embryonic stem cell-derived retinal pigment epithelium cells.
Investigational
Matched Description: … ASP-7317 consists of human embryonic stem cell-derived retinal pigment epithelium cells. …
CLZ-2002 consists of allogeneic mesenchymal stem cells derived neuronal regeneration-promoting cells.
Investigational
Matched Description: … CLZ-2002 consists of allogeneic mesenchymal stem cells derived neuronal regeneration-promoting cells. …
Eprotirome which is a compound with promising properties for treatment of obesity and dyslipidemia. Eprotirome increases the body’s energy consumption and reduces body weight and markedly reduces blood lipids and blood glucose.
Investigational
Matched Description: … Eprotirome which is a compound with promising properties for treatment of obesity and dyslipidemia. …
Danvatirsen is under investigation in clinical trial NCT03334617 (Phase II Umbrella Study of Novel Anti-cancer Agents in Patients With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy.).
Investigational
Matched Description: … Danvatirsen is under investigation in clinical trial NCT03334617 (Phase II Umbrella Study of Novel Anti-cancer …
Inarigivir is under investigation in clinical trial NCT03434353 (Study to Evaluate the Antiviral Activity of Inarigivir (GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)).
Investigational
Matched Description: … Inarigivir is under investigation in clinical trial NCT03434353 (Study to Evaluate the Antiviral Activity of
Gastric inhibitory polypeptide is under investigation in clinical trial NCT03081676 (The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea).
Investigational
Matched Description: … Gastric inhibitory polypeptide is under investigation in clinical trial NCT03081676 (The Effect of GIP …
GS-6620 is under investigation in clinical trial NCT01316237 (A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection).
Investigational
Matched Description: … trial NCT01316237 (A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of
JNJ-54175446 is under investigation in clinical trial NCT02933762 (A Study in Healthy Participants to Evaluate the Effect of JNJ-54175446 on Amyloid Biomarkers and Cytokine Profiles in Cerebrospinal Fluid and Plasma).
Investigational
Matched Description: … investigation in clinical trial NCT02933762 (A Study in Healthy Participants to Evaluate the Effect of
Dovramilast is under investigation in clinical trial NCT01300208 (To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus).
Investigational
Matched Description: … (To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of
SEA-CD70 is an investigational humanized, non-fucosylated monoclonal antibody targeting CD70. SEA-CD70 is under investigation in clinical trial NCT04227847 (A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies).
Investigational
Matched Description: … SEA-CD70 is under investigation in clinical trial NCT04227847 (A Safety Study of SEA-CD70 in Patients …
KC706 is a novel anti-inflammatory drug that works by inhibiting the activity of p38 MAP kinase. KC706 holds potential to treat inflammatory conditions such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and cardiovascular disease.
Investigational
Matched Description: … KC706 is a novel anti-inflammatory drug that works by inhibiting the activity of p38 MAP kinase. …
AGI-1096 is a novel oral antioxidant and selective anti-inflammatory agent that is being developed to address the accelerated inflammation of grafted blood vessels, known as transplant arteritis, common in chronic organ transplant rejection.
Investigational
Matched Description: … and selective anti-inflammatory agent that is being developed to address the accelerated inflammation of
Displaying drugs 6976 - 7000 of 8282 in total